These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Tricyclic antidepressants and monoamine oxidase inhibitors in the treatment of agoraphobia. Pohl R; Berchou R; Rainey JM J Clin Psychopharmacol; 1982 Dec; 2(6):399-407. PubMed ID: 7174863 [TBL] [Abstract][Full Text] [Related]
5. Selective monoamine uptake inhibitors and a serotonin antagonist in the treatment of panic disorder. Westenberg HG; den Boer JA Psychopharmacol Bull; 1989; 25(1):119-23. PubMed ID: 2528158 [No Abstract] [Full Text] [Related]
6. Panic disorder: a treatment update. Burrows GD; Norman TR; Judd FK J Clin Psychiatry; 1991 Jul; 52 Suppl():24-6. PubMed ID: 2071568 [TBL] [Abstract][Full Text] [Related]
14. Panic disorder: response to sodium lactate, and treatment with antidepressants. Rifkin A Psychopharmacol Bull; 1983; 19(3):432-4. PubMed ID: 6635118 [No Abstract] [Full Text] [Related]
15. Monoamine oxidase inhibitors and alprazolam in the treatment of panic disorder and agoraphobia. Sheehan DV Psychiatr Clin North Am; 1985 Mar; 8(1):49-62. PubMed ID: 2859580 [TBL] [Abstract][Full Text] [Related]
16. Decisions for the clinician in the treatment of panic disorder: when to treat, which treatment to use, and how long to treat. Schatzberg AF; Ballenger JC J Clin Psychiatry; 1991 Feb; 52 Suppl():26-31; discussion 32. PubMed ID: 1995599 [TBL] [Abstract][Full Text] [Related]